Business process outsourcing services provider Cognizant has signed a multi-year agreement with AstraZeneca to deliver comprehensive biostatistics and medical reporting services.

Cognizant will provide centralised statistical programming, statistical analysis, medical writing and document publishing services, which will allow AstraZeneca to improve operational efficiency while reducing cycle times and costs.

Go deeper with GlobalData

Go deeper with GlobalData

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

Cognizant will use its proprietary Cognizant 2.0 platform to support knowledge sharing and collaboration across global teams, enabling clinical studies to be managed internationally while delivering productivity benefits to AstraZeneca.

AstraZeneca Clinical Development vice-president and head Karin Wingstrand said that Cognizant’s IT and business process expertise will allow the company to focus more time, energy and investment into developing innovative medicines.

Medical Device Network Excellence Awards - The Benefits of Entering

Gain the recognition you deserve! The Medical Device Network Excellence Awards celebrate innovation, leadership, and impact. By entering, you showcase your achievements, elevate your industry profile, and position yourself among top leaders driving medical devices advancements. Don’t miss your chance to stand out—submit your entry today!

Nominate Now